Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00907_DB04946> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00907_DB04946 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00907_DB04946 label "DDI between Cocaine and Iloperidone - CYP2D6 Inhibitors (Strong) such as cocaine may increase serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolite P88 may be increased. CYP2D6 Inhibitors (Strong) may decrease serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolite P95 may be decreased. CYP2D6 Inhibitors (Strong) may increase the serum concentration of Iloperidone. Reduce iloperidone dose by half when administered with a strong CYP2D6 inhibitor. [drugbank_resource:DB00907_DB04946]" assertion.
- drugbank_resource:DB00907_DB04946 identifier "drugbank_resource:DB00907_DB04946" assertion.
- drugbank_resource:DB00907_DB04946 title "DDI between Cocaine and Iloperidone - CYP2D6 Inhibitors (Strong) such as cocaine may increase serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolite P88 may be increased. CYP2D6 Inhibitors (Strong) may decrease serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolite P95 may be decreased. CYP2D6 Inhibitors (Strong) may increase the serum concentration of Iloperidone. Reduce iloperidone dose by half when administered with a strong CYP2D6 inhibitor." assertion.